• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质基质细胞微环境的分子系统架构。

A molecular systems architecture of the mesenchymal stromal cell microenvironment.

作者信息

Ayyadurai V A Shiva, Deonikar Prabhakar, Radhakrishnan Vishvatha, Keating Armand

机构信息

Systems Biology Group, CytoSolve Research Division, CytoSolve, Inc., Cambridge, MA 02138, United States.

Open Science Institute, International Center for Integrative Systems, Cambridge, MA 02138, United States.

出版信息

Stem Cells. 2025 Aug 22;43(9). doi: 10.1093/stmcls/sxaf042.

DOI:10.1093/stmcls/sxaf042
PMID:40843515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12371236/
Abstract

A systems-level understanding of immunomodulatory, regenerative, and pro-/antifibrosis functions of mesenchymal stromal cells (MSCs) is critical to advance MSCs as a viable therapeutic option. Given the complexity of MSCs and their interactions with microenvironmental cells, a systems biology approach may enable such understanding to achieve practical objectives such as target identification, combination therapeutics, clinical strategies, and avoidance of adverse effects. In this study, a molecular systems architecture of MSCs microenvironment is developed to organize the complexity of biomolecular interactions between MSCs and other microenvironmental cells. This architecture provides a visual mapping of MSC interactions, identifies the complex crosstalk between MSCs and cells in the microenvironment, reveals potential targets, and offers a framework for creating future predictive, quantitative computational (in silico) models of the MSC microenvironment. The development of combination therapeutics, clinical strategies to improve therapeutic efficacy, and avoidance of adverse effects can be facilitated by such in silico models. However, it must all begin with a molecular systems architecture of MSCs-the objective and result of this study.

摘要

从系统层面理解间充质基质细胞(MSC)的免疫调节、再生及促/抗纤维化功能,对于将MSC发展成为一种可行的治疗选择至关重要。鉴于MSC及其与微环境细胞相互作用的复杂性,系统生物学方法可能有助于实现诸如靶点识别、联合治疗、临床策略制定以及避免不良反应等实际目标。在本研究中,构建了MSC微环境的分子系统架构,以梳理MSC与其他微环境细胞之间生物分子相互作用的复杂性。该架构提供了MSC相互作用的可视化图谱,识别了MSC与微环境中细胞之间的复杂串扰,揭示了潜在靶点,并为创建未来预测性、定量计算(计算机模拟)的MSC微环境模型提供了框架。此类计算机模拟模型有助于联合治疗的开发、提高治疗效果的临床策略制定以及避免不良反应。然而,这一切都必须始于MSC的分子系统架构——本研究的目标和成果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/21e6b9baa792/sxaf042_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/71d5e8caa304/sxaf042_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/687a7d7a966a/sxaf042_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/6c73c90f8a6f/sxaf042_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/0a875aebe97c/sxaf042_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/a76d97d4f5ea/sxaf042_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/944b8f1e4e45/sxaf042_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/21e6b9baa792/sxaf042_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/71d5e8caa304/sxaf042_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/687a7d7a966a/sxaf042_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/6c73c90f8a6f/sxaf042_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/0a875aebe97c/sxaf042_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/a76d97d4f5ea/sxaf042_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/944b8f1e4e45/sxaf042_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a2/12371236/21e6b9baa792/sxaf042_fig6.jpg

相似文献

1
A molecular systems architecture of the mesenchymal stromal cell microenvironment.间充质基质细胞微环境的分子系统架构。
Stem Cells. 2025 Aug 22;43(9). doi: 10.1093/stmcls/sxaf042.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Mesenchymal stem cells in the bone marrow microenvironment: a double-edged sword for AML.骨髓微环境中的间充质干细胞:急性髓系白血病的双刃剑
J Cancer Res Clin Oncol. 2025 Jun 21;151(6):193. doi: 10.1007/s00432-025-06244-4.
4
Probing the effects of polysaccharide hydrogel composition on the viability and pro-angiogenic function of human adipose-derived stromal cells.探究多糖水凝胶成分对人脂肪来源间充质干细胞活力和促血管生成功能的影响。
J Biomed Mater Res A. 2025 Jan;113(1):e37800. doi: 10.1002/jbm.a.37800. Epub 2024 Sep 20.
5
Harnessing mesenchymal stem/stromal cells-based therapies for rheumatoid arthritis: mechanisms, clinical applications, and microenvironmental interactions.利用基于间充质干/基质细胞的疗法治疗类风湿性关节炎:作用机制、临床应用及与微环境的相互作用
Stem Cell Res Ther. 2025 Jul 16;16(1):379. doi: 10.1186/s13287-025-04495-z.
6
Modulating the mesenchymal stromal cell microenvironment alters exosome RNA content and ligament healing capacity.调控间充质基质细胞微环境可改变外泌体 RNA 含量和韧带愈合能力。
Stem Cells. 2024 Jul 8;42(7):636-649. doi: 10.1093/stmcls/sxae028.
7
Natural compounds and mesenchymal stem cells: implications for inflammatory-impaired tissue regeneration.天然化合物与间充质干细胞:在炎症受损组织再生中的作用。
Stem Cell Res Ther. 2024 Feb 7;15(1):34. doi: 10.1186/s13287-024-03641-3.
8
Mesenchymal stromal/stem cells promote intestinal epithelium regeneration after chemotherapy-induced damage.间充质基质/干细胞促进化疗诱导损伤后的肠道上皮细胞再生。
Stem Cell Res Ther. 2024 Apr 29;15(1):125. doi: 10.1186/s13287-024-03738-9.
9
Short-Term Memory Impairment短期记忆障碍
10
Modified mesenchymal stromal cells by in vitro transcribed mRNA: a therapeutic strategy for hepatocellular carcinoma.经体外转录 mRNA 修饰的间充质基质细胞:肝细胞癌的治疗策略。
Stem Cell Res Ther. 2024 Jul 11;15(1):208. doi: 10.1186/s13287-024-03806-0.

本文引用的文献

1
A molecular systems architecture of neuromuscular junction in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中神经肌肉接头的分子系统架构
NPJ Syst Biol Appl. 2025 Mar 17;11(1):27. doi: 10.1038/s41540-025-00501-5.
2
Gingival mesenchymal stem cells: Biological properties and therapeutic applications.牙龈间充质干细胞:生物学特性与治疗应用
J Oral Biol Craniofac Res. 2024 Sep-Oct;14(5):547-569. doi: 10.1016/j.jobcr.2024.07.003. Epub 2024 Jul 13.
3
Migrasomes from adipose derived stem cells enrich CXCL12 to recruit stem cells via CXCR4/RhoA for a positive feedback loop mediating soft tissue regeneration.
脂肪来源干细胞衍生的迁移小体通过 CXCR4/RhoA 富集 CXCL12 招募干细胞,形成一个正反馈回路,介导软组织再生。
J Nanobiotechnology. 2024 May 3;22(1):219. doi: 10.1186/s12951-024-02482-9.
4
Recent progress in mesenchymal stem cell-based therapy for acute lung injury.间充质干细胞治疗急性肺损伤的研究进展。
Cell Tissue Bank. 2024 Jun;25(2):677-684. doi: 10.1007/s10561-024-10129-0. Epub 2024 Mar 11.
5
Mesenchymal stromal cell derived extracellular vesicles as a therapeutic tool: immune regulation, MSC priming, and applications to SLE.间充质基质细胞衍生的细胞外囊泡作为一种治疗工具:免疫调节、MSC 启动及其在 SLE 中的应用。
Front Immunol. 2024 Feb 8;15:1355845. doi: 10.3389/fimmu.2024.1355845. eCollection 2024.
6
The Regulatory Network of CREB3L1 and Its Roles in Physiological and Pathological Conditions.CREB3L1 的调控网络及其在生理和病理条件下的作用。
Int J Med Sci. 2024 Jan 1;21(1):123-136. doi: 10.7150/ijms.90189. eCollection 2024.
7
Inflammation-inducible promoters to overexpress immune inhibitory factors by MSCs.通过间充质干细胞过表达免疫抑制因子的炎症诱导型启动子。
Stem Cell Res Ther. 2023 Sep 23;14(1):270. doi: 10.1186/s13287-023-03501-6.
8
Unlocking the Potential of Mesenchymal Stem Cells in Gynecology: Where Are We Now?释放间充质干细胞在妇科领域的潜力:我们目前进展如何?
J Pers Med. 2023 Aug 13;13(8):1253. doi: 10.3390/jpm13081253.
9
Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.间充质基质细胞衍生的细胞外囊泡在软骨细胞炎症中的免疫调节潜力。
Front Immunol. 2023 Jul 26;14:1198198. doi: 10.3389/fimmu.2023.1198198. eCollection 2023.
10
The formation of migrasomes is initiated by the assembly of sphingomyelin synthase 2 foci at the leading edge of migrating cells.迁移小体的形成是由迁移细胞前缘鞘磷脂合成酶 2 焦点的组装引发的。
Nat Cell Biol. 2023 Aug;25(8):1173-1184. doi: 10.1038/s41556-023-01188-8. Epub 2023 Jul 24.